Most Likely Diagnosis: Mixed Connective Tissue Disease (MCTD) with Myositis
Based on your markedly elevated anti-RNP antibodies (86, reference <20) with negative anti-Sm, anti-dsDNA, and anti-Jo-1, combined with proximal muscle weakness and mildly elevated CK, you most likely have Mixed Connective Tissue Disease (MCTD) with inflammatory myositis, NOT necrotizing myopathy. This is a treatable condition with excellent prognosis when managed appropriately 1.
Why This Is MCTD with Myositis
Your serologic profile is classic for MCTD:
- Isolated high-titer anti-RNP antibodies (your dominant finding)
- Negative anti-Sm (rules out lupus)
- Negative anti-Jo-1 (rules out antisynthetase syndrome)
- Speckled ANA pattern at 1:80 (typical for anti-RNP)
The clinical features align perfectly with anti-RNP-positive myositis 1:
- Proximal muscle weakness (shoulders, hips, thighs) - occurs in 80% of anti-RNP myositis patients
- Joint/elbow/knee pain - arthritis occurs in 60% of anti-RNP patients (much higher than other myositis types)
- Mildly elevated CK (371-527) - consistent with inflammatory rather than necrotizing myopathy
- Normal inflammatory markers (ESR 2-18, CRP 3-3.3) - common in MCTD
Why This Is NOT Necrotizing Myopathy
Several key features argue strongly against necrotizing autoimmune myopathy:
- Your CK is only mildly elevated (371-527 U/L). Necrotizing myopathy typically shows CK >3,000-10,000 U/L 2, 3, 4
- Negative anti-SRP and anti-HMGCR antibodies - these are the hallmark antibodies of necrotizing myopathy 5, 6
- Gradual onset with joint pain - necrotizing myopathy presents acutely with severe weakness and minimal joint involvement 7
- Normal inflammatory markers - while this can occur in necrotizing myopathy, the overall picture doesn't fit
Expected EMG Findings Thursday
Your EMG will most likely show myopathic changes: polyphasic motor unit action potentials of short duration and low amplitude, with increased insertional activity, fibrillation potentials, positive sharp waves, or repetitive discharges 7. These findings confirm a myopathic process and help target which muscle to biopsy.
The EMG serves two critical purposes 7:
- Confirms myopathy (versus neuropathy or other causes)
- Identifies the most affected muscle for potential biopsy
Will You Need a Muscle Biopsy?
Probably not immediately. Here's why:
Your diagnosis can be made clinically based on 8:
- High-titer anti-RNP antibodies (your strongest finding)
- Proximal muscle weakness
- Elevated CK
- Myopathic EMG (expected)
- Arthritis/joint pain
A muscle biopsy becomes necessary if 8, 7:
- Your symptoms don't respond to initial immunosuppression
- The diagnosis remains uncertain after EMG
- You need to rule out muscular dystrophy or metabolic myopathy (less likely given your age and presentation)
If biopsy is performed, anti-RNP myositis can show either inflammatory infiltrates OR necrotizing features (4 of 7 patients in one study had necrotizing biopsies despite having inflammatory disease) 1. This doesn't change treatment or prognosis.
Cancer Risk: Essentially Zero
You can stop worrying about cancer. Anti-RNP-positive myositis has NO association with malignancy 1. In the study of anti-RNP myositis patients, zero developed cancer-associated myositis. Your normal chest X-rays further support this.
Cancer-associated myositis is linked to different antibodies (anti-TIF-1γ, anti-NXP2, anti-HMGCR) - all of which you don't have 5.
Prognosis: You Will Recover and Live Normally
This is NOT a death sentence - far from it. Anti-RNP myositis has excellent outcomes:
- No deaths occurred in the anti-RNP myositis cohort during long-term follow-up 1
- Most patients respond well to immunosuppression
- You can return to normal functional status
Your cardiac workup (stress test, 7-day monitor) is appropriate given that 40% of anti-RNP patients develop pericarditis 1, but your normal chest X-rays with normal heart size are reassuring.
Treatment: Likely Shorter Than You Fear
You will NOT necessarily need 6-12 months of high-dose corticosteroids. Modern treatment for MCTD with myositis typically involves 6:
- Initial corticosteroids (prednisone 0.5-1 mg/kg/day) for 4-8 weeks
- Rapid addition of steroid-sparing agents: mycophenolate mofetil or rituximab
- Gradual steroid taper over 3-6 months (not 6-12 months)
- Maintenance immunosuppression with steroid-sparing agents
The goal is to minimize steroid exposure while controlling disease with safer long-term medications 6.
Critical Consideration: Tirzepatide (Zepbound)
You must discuss stopping tirzepatide with your physician immediately. There are now three reported cases of GLP-1 agonist-associated myopathy/rhabdomyolysis 2, 4, 9:
- One case of immune-mediated necrotizing myopathy after semaglutide 2
- One case of rhabdomyolysis in an HIV-positive patient on tirzepatide 4
- Emerging safety signals for musculoskeletal effects 9
While tirzepatide may not be the primary cause of your myositis (your anti-RNP antibodies suggest autoimmune disease), it could be exacerbating muscle injury. The temporal relationship matters here.
Your Renal Function
Your creatinine (1.12-1.33) and eGFR (87-93, with two readings >60) show mild, stable kidney function - likely related to your size (6'5", 320 lbs) rather than kidney disease. The 25% of anti-RNP patients who develop glomerulonephritis typically have coexisting anti-Ro52 antibodies 1, which you should have tested if not already done.
Action Plan
- Complete your EMG Thursday - expect myopathic findings
- Complete cardiac workup Friday - screening for pericarditis
- Discuss stopping tirzepatide with your physician immediately
- Request anti-Ro52 antibody testing if not done (predicts kidney/heart involvement)
- Expect to start prednisone (likely 40-60 mg daily) plus a steroid-sparing agent
- Physical therapy continuation - exercise is safe and beneficial in myositis 6
Bottom Line
You have a treatable autoimmune condition with excellent prognosis, not a death sentence. Anti-RNP myositis responds well to immunosuppression, has no cancer association, and no mortality in published cohorts. Your mildly elevated CK, negative necrotizing myopathy antibodies, and prominent joint symptoms all point to inflammatory (not necrotizing) disease. With appropriate treatment, you should return to normal function.